Department of Obstetrics and Gynecology, Alpert Medical School, Brown University, Providence, RI, USA.
Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):6013-6020. doi: 10.1080/14767058.2021.1903862. Epub 2021 Apr 1.
To determine the impact of prior vaginal birth on neonatal and maternal outcomes among individuals undergoing a trial of labor after two cesarean births.
This was a cross-sectional study using the U.S. National Vital Statistics 2014-2018 period linked birth and infant death data. Inclusion criteria were term, cephalic, singleton pregnancies with two prior cesarean births. The primary exposure variable was a trial of labor after cesarean vs prelabor repeat cesarean birth. Cohorts were defined by the presence or absence of a prior vaginal birth. The primary outcome was a composite of adverse neonatal outcomes (Apgar score <5 at 5 min, assisted ventilation >6 h, neonatal seizures, or neonatal death within 27 days). Secondary outcomes included a maternal composite and the cesarean birth rate. Propensity score matching was used to account for baseline differences in treatment allocation within each cohort, and conditional logistic regression assessed the association between the exposure and outcomes.
The composite neonatal adverse outcome was significantly higher in those undergoing a trial of labor after cesarean compared to prelabor repeat cesarean birth in both individuals without a prior vaginal birth (8.2 vs 11.6 per 1000 live births, OR 1.41; 95% CI 1.12-1.70) and with a prior vaginal birth (9.6 vs 12.4 per 1000 live births, OR 1.30; 95% CI 1.08-1.57). The composite maternal adverse outcome was significantly higher among individuals without a prior vaginal birth undergoing trial of labor after cesarean (6.0 vs 9.5 per 1000 live births, OR 1.59; 95% CI 1.26-2.09), but was similar in those with a prior vaginal birth (7.9 vs 9.3 per 1000 live births, OR 1.18; 95% CI 0.97-1.46).
In individuals with two prior cesarean births, trial of labor after cesarean was associated with increased neonatal adverse outcomes when compared to prelabor repeat cesarean birth, irrespective of a history of vaginal birth. In individuals with a prior vaginal birth, the composite maternal adverse outcome was not elevated in the trial of labor cohort.
本研究旨在探讨两次剖宫产术后试产对既往阴道分娩者的新生儿和产妇结局的影响。
本研究为回顾性队列研究,使用了美国国家生命统计系统 2014-2018 年期间的母婴死亡数据。纳入标准为足月、头位、单胎妊娠,且有两次剖宫产史。主要暴露变量为剖宫产术后试产与术前重复剖宫产。根据既往是否有阴道分娩将队列分为两组。主要结局为不良新生儿结局(5 分钟时 Apgar 评分<5、辅助通气>6 小时、新生儿惊厥或出生后 27 天内死亡)复合指标。次要结局包括产妇复合结局和剖宫产率。采用倾向评分匹配法校正每组内治疗分配的基线差异,采用条件逻辑回归评估暴露与结局之间的关系。
在既往无阴道分娩者中,与术前重复剖宫产相比,剖宫产术后试产的新生儿不良结局复合指标更高(无阴道分娩者中分别为 8.2/1000 活产和 11.6/1000 活产,比值比 1.41,95%置信区间 1.12-1.70;有阴道分娩者中分别为 9.6/1000 活产和 12.4/1000 活产,比值比 1.30,95%置信区间 1.08-1.57)。在既往无阴道分娩者中,与术前重复剖宫产相比,剖宫产术后试产的产妇不良结局复合指标更高(无阴道分娩者中分别为 6.0/1000 活产和 9.5/1000 活产,比值比 1.59,95%置信区间 1.26-2.09;有阴道分娩者中分别为 7.9/1000 活产和 9.3/1000 活产,比值比 1.18,95%置信区间 0.97-1.46)。
在两次剖宫产史的患者中,与术前重复剖宫产相比,剖宫产术后试产与新生儿不良结局增加相关,而与既往阴道分娩史无关。在有阴道分娩史的患者中,试产组的产妇不良结局复合指标并未升高。